Please login to the form below

Not currently logged in
Email:
Password:

Apellis

This page shows the latest Apellis news and features for those working in and with pharma, biotech and healthcare.

FDA approves Apellis’ Empaveli for rare blood disease

FDA approves Apellis’ Empaveli for rare blood disease

Whereas Alexion’s Soliris and its follow-up therapy Ultomiris target the C5 pathway, Apellis’ drug targets the compliment protein C3 – the central protein in the complement cascade. ... Apellis is also conducting a study of Empaveli in

Latest news

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Dr Robert Kim joins Apellis as chief medical officer Dr Robert Kim joins Apellis as chief medical officer

    Brings experience from Novartis, Genentech and GSK. Dr Robert Kim has taken up a role at Apellis Pharmaceuticals as chief medical officer, bringing to the US clinical stage immunotherapy company experience ... In his new role at Louisville,

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....